Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IGF2BP3 promotes mRNA degradation through internal m7G modification. | Nat Commun | 2024 | 39198433 | PubTator, text mining | PubMed |
| The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas. | Acta Neuropathol | 2024 | 39179895 | PubTator, text mining | PubMed |
| METTL3 and IGF2BP1-Mediated m6A Modification of ZHX2 Promotes Tumor Property of Renal Cell Carcinoma. | Kidney Blood Press Res | 2024 | 39159608 | PubTator, text mining | PubMed |
| LncRNA GHET1 from bone mesenchymal stem cell-derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3. | Sci Rep | 2024 | 39154102 | PubTator, text mining | PubMed |
| SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma. | Transl Cancer Res | 2024 | 39145091 | PubTator, text mining | PubMed |
| IGF2BP1-Mediated Regulation of CCN1 Expression by Specific Binding to G-Quadruplex Structure in Its 3'UTR. | Biochemistry | 2024 | 39133064 | PubTator, text mining | PubMed |
| METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1. | Thorac Cancer | 2024 | 39090761 | PubTator, text mining | PubMed |
| LINC00513 promotes colorectal cancer malignant progression by binding with IGF2BP1 to enhance the stability of connective tissue growth factor mRNA. | Epigenomics | 2024 | 39072366 | PubTator, text mining | PubMed |
| ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation. | Cancer Gene Ther | 2024 | 39069526 | PubTator, text mining | PubMed |
| Overexpression of insulin-like growth factor-2 mRNA-binding protein 1 is associated with periodontal disease. | J Oral Biol Craniofac Res | 2024 | 39050526 | PubTator, text mining | PubMed |
| Identification of ASMTL-AS1 and LINC02604 lncRNAs as novel biomarkers for diagnosis of colorectal cancer. | Int J Colorectal Dis | 2024 | 39028420 | PubTator, text mining | PubMed |
| Consensus clustering and novel risk score model construction based on m6A methylation regulators to evaluate the prognosis and tumor immune microenvironment of early-stage lung adenocarcinoma. | Aging (Albany NY) | 2024 | 39028290 | PubTator, text mining | PubMed |
| FTO-mediated RNA m6A methylation regulates synovial aggression and inflammation in rheumatoid arthritis. | Biochim Biophys Acta Mol Basis Dis | 2024 | 39025373 | PubTator, text mining | PubMed |
| A novel nomogram model for lung adenocarcinoma subtypes based on RNA-modification regulatory genes. | Heliyon | 2024 | 39022104 | PubTator, text mining | PubMed |
| METTL14 plays an oncogenic role in NSCLC by modulating ferroptosis and the m6A modification of GPX4. | Arch Physiol Biochem | 2024 | 38993012 | PubTator, text mining | PubMed |
| LncRNA SNHG5/IGF2BP1/Occludin axis regulates Nd2O3 induced blood-testis barrier disruption. | Environ Pollut | 2024 | 38992831 | PubTator, text mining | PubMed |
| Protein Condensate Atlas from predictive models of heteromolecular condensate composition. | Nat Commun | 2024 | 38987300 | PubTator, text mining | PubMed |
| RNA-binding proteins in bone pathophysiology. | Front Cell Dev Biol | 2024 | 38966428 | PubTator, text mining | PubMed |
| A novel lncRNA LOC101928222 promotes colorectal cancer angiogenesis by stabilizing HMGCS2 mRNA and increasing cholesterol synthesis. | J Exp Clin Cancer Res | 2024 | 38965575 | PubTator, text mining | PubMed |
| Synthesis and Evaluation of Carbapenem/Metallo-β-Lactamase Inhibitor Conjugates. | ChemMedChem | 2024 | 38946213 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers?page=16